KEI asks WHO to include risdiplam, treatment for Spinal Muscular Atrophy, on the Essential Medicines List (EML)
Access to Medicine
SCP 34: WIPO patent committee charts a course for the examination of voluntary and compulsory licensing practices during the Covid-19 pandemic
On Friday, 30 September 2022, at the Geneva headquarters of the World Intellectual Property Organization (WIPO), the 34th session of Standing Committee on the Law of Patents (SCP) adopted a future work plan for WIPO’s patent committee on patents and… Continue Reading
166 contracts disclosed in SEC filings include authorizations to use U.S. patents without consent from patent holders
On 12 October 2022, Knowledge Ecology International (KEI) published a briefing note on the U.S. federal government FAR 52.227-1 authorizations (for non voluntary use of patents) disclosed in 166 SEC exhibits. KEI Briefing Note 2022:2, Federal government FAR 52.227-1 authorizations… Continue Reading
WIPO SCP 34: KEI statement on patents and health
On Tuesday, 27 September 2022, Knowledge Ecology International (KEI) delivered the following oral statement during discussions on patents and health at the 34th session of the WIPO Standing Committee on the Law of Patents (SCP). In July 2022, KEI published… Continue Reading
Informal, focused consultations (IFCs) on WHO’s pandemic treaty to address: 1) legal matters, 2) equity, 3) IP and access to pandemic response products, and 4) One Health, AMR, Climate and Zoonosis
As part of ongoing WHO negotiations on a pandemic treaty, the WHO secretariat is set to convene four informal, focused consultations (IFCs) on the following themes: 1) legal matters, 2) operationalizing and achieving equity, 3) intellectual property and access to… Continue Reading
7 July 2022: Human Rights Council adopts resolution on right to health resolution with references delinkage, solidarity, global public good, and the transfer of technology and know-how
On Thursday, 7 July 2022, the 40th session of the Human Rights Council (HRC) adopted, by consensus, a resolution on Access to medicines, vaccines and other health products in the context of the right of everyone to the enjoyment of… Continue Reading
KEI review of 62 COVID 19 contracts reveals 59 authorizations for non-voluntary use of third party patents under 28 USC 1498
Since the COVID 19 Pandemic began, there has been a spirited debate over patent rights, including a highly publicized 20 month debate over a proposed WTO waiver on intellectual property rights. During that time a handful of countries have taken… Continue Reading
KEI Briefing Note 2022:1, Selected U.S. Government COVID Contracts with Authorization and Consent to Non-Voluntary Use Of Third Party Patents
WIPO General Assembly 2022: General statement of Knowledge Ecology International
On Friday, 15 July 2022 Knowledge Ecology International delivered the following opening statement at the 2022 WIPO General Assembly. The COVID pandemic illustrates flaws in the intellectual property system. In a public health crisis, no company should have a monopoly… Continue Reading
KEI letter to Roche requesting voluntary license to patents on risdiplam, a treatment for Spinal Muscular Atrophy (SMA)